Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01444378 · ClinicalTrials.gov registry record · NA
Absolute Pro® MOMENTUM™
A NA study of Peripheral Artery Disease and Peripheral Vascular Disease, sponsored by Abbott Medical Devices.
- Completed
- Registry status
- NA
- Development phase
- 141
- Enrollment target
- 1
- Study location
NCT01444378: Completed NA study of Peripheral Artery Disease and Peripheral Vascular Disease, sponsored by Abbott Medical Devices.
NCT01444378 is a NA study of Peripheral Artery Disease and Peripheral Vascular Disease that has completed, run by Abbott Medical Devices. The registered enrollment target is 141 participants, above the 124-participant average among 50 other Peripheral Artery Disease trials with a reported enrollment target (14% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01444378, a NA study of Peripheral Artery Disease and Peripheral Vascular Disease, has completed, sponsored by Abbott Medical Devices.
- COMPLETED
- Registry status
- NA
- Development phase
- 141 participants
- Enrollment target
- 1
- Study location
Study Summary
To evaluate the safety and effectiveness of the Absolute Pro® Peripheral Self-Expanding Stent System and the Absolute Pro® LL Peripheral Self-Expanding Stent System for the treatment of subjects with atherosclerotic de novo or restenotic lesions in the native superficial femoral artery (SFA) and/or the native proximal popliteal artery (PPA). CAUTION: Absolute Pro® Peripheral Self-Expanding Stent System and the Absolute Pro® LL Peripheral Self-Expanding Stent Systems are investigational devices. Limited by Federal (U.S.) law to investigational use only.
Primary Outcome
Primary safety endpoint is freedom from MAE which is defined as a composite of: * Death due to all causes * Index limb major amputation (at or above the ankle) * Clinically-driven target lesion revascularization (TLR)
Conditions Studied
Interventions
- DEVICE Stenting using Absolute Pro® and Pro LL® Peripheral Stent Systems
Study Locations (1)
California
- Abbott Vascular - Santa Clara
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 141 participants |
| Start Date | 2011-10 |
| Est. Completion | 2015-05 |
| Phase | NA |
What the finished NCT01444378 record still lists
NCT01444378 is an interventional study that assigns participants to a tested intervention. The registered 141 participants enrollment target is mid-sized for trials with a published cap, above the 124-participant average among 50 other Peripheral Artery Disease trials with a reported enrollment target (14% higher).
The record links to 2 conditions, with Peripheral Artery Disease appearing as the primary indexed condition, and to 1 intervention - of which Stenting using Absolute Pro® and Pro LL® Peripheral Stent Systems is the first listed.
NCT01444378 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT01444378 about?
NCT01444378 is a clinical study titled "Absolute Pro® MOMENTUM™". To evaluate the safety and effectiveness of the Absolute Pro® Peripheral Self-Expanding Stent System and the Absolute Pro® LL Peripheral Self-Expanding Stent System for the treatment of subjects with atherosclerotic de novo or restenotic lesions in the native superficial femoral artery (SFA) and/or ...
What is the current status of trial NCT01444378?
This trial is currently completed. It is a NA study. The enrollment target is 141 participants. The study started on 2011-10. Estimated completion is 2015-05.
What conditions does trial NCT01444378 study?
This clinical trial studies the following conditions: Peripheral Artery Disease, Peripheral Vascular Disease.
What interventions are being tested in trial NCT01444378?
The interventions under investigation include: Stenting using Absolute Pro® and Pro LL® Peripheral Stent Systems (DEVICE).
Who is sponsoring clinical trial NCT01444378?
This trial is sponsored by Abbott Medical Devices, which has 261 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01444378 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Peripheral Artery Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01444378's enrollment target sits among peer trials
141 21st of 50 higher than 30 of 50 other Peripheral Artery Disease trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Peripheral Artery Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
The Effects of a Novel, Non-ischemic and Pain-free Exercise Intervention in Peripheral Artery Disease
RECRUITING · NA
-
BEETroot Juice to Reverse Functional Impairment in PAD
RECRUITING · NA
-
Telehealth Delivered Home-based Walking for Vets With Peripheral Artery Disease
RECRUITING · NA
-
The THOR IDE Study
RECRUITING · NA
-
Randomized Controlled Trial of Alert-Based Computerized Decision Support for Patients With Peripheral Artery Disease Not Prescribed Lipid-Lowering Therapy
RECRUITING · NA
-
Leg Heat Therapy in Peripheral Artery Disease
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03042962 · 141 participants
Brain Networks in Dystonia
- NCT04378439 · 141 participants · NA
Appalachian Partnership to Reduce Disparities (Aim 2)
- NCT04775485 · 141 participants · Phase 2
A Study to Evaluate Tovorafenib in Pediatric and Young Adult Participants With Relapsed or Progressive Low-Grade Glioma and Advance Solid Tumors
- NCT05040360 · 141 participants · Phase 2
Testing the Use of Chemotherapy After Surgery for High-Risk Pancreatic Neuroendocrine Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia